The National Women’s Hockey League today announced a new policy for transgender athletes.
“This is an opportunity to move the conversation forward and accelerate social progress,” said NWHL Commissioner Dani Rylan in a release. “The NWHL wants to be a reference point and resource for the next player or league that may feel uncertain or underprepared for their moment.”
For those players designated female at birth, it has been ruled that they “may not take testosterone hormone therapy. Athletes transitioning to male who undergo hormone therapy will be ineligible to compete.”
For athletes transitioning to female, the “athlete must demonstrate that her total testosterone level in serum is within typical limits of women athletes.”
And read more in this story by the New York Times.